» Articles » PMID: 27060051

Multiple Antigens of Yersinia Pestis Delivered by Live Recombinant Attenuated Salmonella Vaccine Strains Elicit Protective Immunity Against Plague

Overview
Journal Vaccine
Date 2016 Apr 10
PMID 27060051
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Based on our improved novel Salmonella vaccine delivery platform, we optimized the recombinant attenuated Salmonella typhimurium vaccine (RASV) χ12094 to deliver multiple Yersinia pestis antigens. These included LcrV196 (amino acids, 131-326), Psn encoded on pYA5383 and F1 encoded in the chromosome, their synthesis did not cause adverse effects on bacterial growth. Oral immunization with χ12094(pYA5383) simultaneously stimulated high antibody titers to LcrV, Psn and F1 in mice and presented complete protection against both subcutaneous (s.c.) and intranasal (i.n.) challenges with high lethal doses of Y. pestis CO92. Moreover, no deaths or other disease symptoms were observed in SCID mice orally immunized with χ12094(pYA5383) over a 60-day period. Therefore, the trivalent S. typhimurium-based live vaccine shows promise for a next-generation plague vaccine.

Citing Articles

Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination.

Nazir J, Manzoor T, Saleem A, Gani U, Bhat S, Khan S BMC Infect Dis. 2025; 25(1):84.

PMID: 39833704 PMC: 11744889. DOI: 10.1186/s12879-025-10478-5.


The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice.

Hendrix E, Sha J, Kilgore P, Neil B, Verma A, Chopra A Vaccines (Basel). 2025; 12(12.

PMID: 39772023 PMC: 11680114. DOI: 10.3390/vaccines12121361.


Progress on the research and development of plague vaccines with a call to action.

Williamson E, Kilgore P, Hendrix E, Neil B, Sha J, Chopra A NPJ Vaccines. 2024; 9(1):162.

PMID: 39242587 PMC: 11379892. DOI: 10.1038/s41541-024-00958-1.


Protective immunity enhanced vaccine vectors delivering antigens reduce stomach colonization in mice.

Ghasemi A, Wang S, Sahay B, Abbott J, Curtiss 3rd R Front Immunol. 2022; 13:1034683.

PMID: 36466847 PMC: 9716130. DOI: 10.3389/fimmu.2022.1034683.


Immunogenicity and protection efficacy of enhanced fitness recombinant Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis.

Loh F, Nathan S, Chow S, Fang C Pathog Glob Health. 2021; 115(6):392-404.

PMID: 33525974 PMC: 8592622. DOI: 10.1080/20477724.2021.1881369.


References
1.
Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda S . Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A. 2008; 106(2):593-8. PMC: 2626748. DOI: 10.1073/pnas.0811697106. View

2.
Smiley S . Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines. 2008; 7(2):209-21. PMC: 2365752. DOI: 10.1586/14760584.7.2.209. View

3.
Erova T, Rosenzweig J, Sha J, Suarez G, Sierra J, Kirtley M . Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Clin Vaccine Immunol. 2012; 20(2):227-38. PMC: 3571283. DOI: 10.1128/CVI.00597-12. View

4.
Torres-Escobar A, Juarez-Rodriguez M, Branger C, Curtiss 3rd R . Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA. Vaccine. 2010; 28(36):5810-6. PMC: 2921469. DOI: 10.1016/j.vaccine.2010.06.070. View

5.
Quenee L, Ciletti N, Berube B, Krausz T, Elli D, Hermanas T . Plague in Guinea pigs and its prevention by subunit vaccines. Am J Pathol. 2011; 178(4):1689-700. PMC: 3078462. DOI: 10.1016/j.ajpath.2010.12.028. View